Activity of enzalutamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel (Q35602518)
Jump to navigation
Jump to search
scientific article published on 20 January 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Activity of enzalutamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel |
scientific article published on 20 January 2015 |
Statements
1 reference
Activity of enzalutamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel (English)
1 reference
H H Cheng
R Gulati
A Azad
R Nadal
P Twardowski
N Agarwal
E I Heath
S K Pal
H-T Rehman
A Leiter
J A Batten
R B Montgomery
M D Galsky
E S Antonarakis
K N Chi
20 January 2015
1 reference
1 reference
1 reference
1 reference
1 reference